Clinical Trial of 0.02% Polyhexamethylene Biguanide Versus Placebo in the Treatment of Microsporidial Keratoconjunctivitis

American Journal of Ophthalmology

Volumn 150, Issue 1, 2010, Pages

  Das, Sujata ^a   Sahu, Srikant K ^a   Sharma, Savitri ^a   Nayak, Shyam Sundar ^a   Kar, Sarita ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; PLACEBO; POLY(HEXAMETHYLENEBIGUANIDE);

ADULT; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA LESION; DETERIORATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; KERATOCONJUNCTIVITIS; MAJOR CLINICAL STUDY; MALE; MICROSPORIDIA; MICROSPORIDIAN SPORE; MICROSPORIDIOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 77955675652     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.01.038     Document Type: Article

References (15)

1. Weber R., Bryan R.T., Schwartz D.A., and Owen R.L. Human microsporidial infections. Clin Microbiol Rev 7 4 (1994) 426-461
2. Joseph J., Vemuganti G.K., and Sharma S. Microsporidia: emerging ocular pathogens. Indian J Med Microbiol 23 2 (2005) 80-91
3. Lowder C.Y., McMahon J.T., Meisler D.M., et al. Microsporidial keratoconjunctivitis caused by Septata intestinalis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 121 6 (1996) 715-717
4. Martins S.A., Muccioli C., Belfort Jr. R., and Castelo A. Resolution of microsporidial keratoconjunctivitis in an AIDS patient treated with highly active antiretroviral therapy. Am J Ophthalmol 131 3 (2001) 378-379
5. Rosberger D.F., Serdarevic O.N., Erlandson R.A., et al. Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 12 3 (1993) 261-265
6. McCluskey P.J., Goonan P.V., Marriott D.J., and Field A.S. Microsporidial keratoconjunctivitis in AIDS. Eye 7 Pt1 (1993) 80-83
7. Joseph J., Sridhar M.S., Murthy S., and Sharma S. Clinical and microbiological profile of microsporidial keratoconjunctivitis in southern India. Ophthalmology 113 4 (2006) 531-537
8. Chan C.M., Theng J.T., Li L., and Tan D.T. Microsporidial keratoconjunctivitis in healthy individuals: a case series. Ophthalmology 110 7 (2003) 1420-1425
9. Das S., Sharma S., Sahu S.K., Nayak S.S., and Kar S. New microbial spectrum of epidemic keratoconjunctivitis: clinical and laboratory aspects of an outbreak. Br J Ophthalmol 92 6 (2008) 861-862
10. Sridhar M.S., and Sharma S. Microsporidial keratoconjunctivitis in a HIV-seronegative patient treated with debridement and oral itraconazole. Am J Ophthalmol 136 4 (2003) 745-746
11. Gritz D.C., Holsclaw D.S., Neger R.E., Whitcher Jr. J.P., and Margolis T.P. Ocular and sinus microsporidial infection cured with systemic albendazole. Am J Ophthalmol 124 2 (1997) 241-243
12. Yee R.W., Tio F.O., Martinez J.A., Held K.S., Shadduck J.A., and Didier E.S. Resolution of microsporidial epithelial keratopathy in a patient with AIDS. Ophthalmology 98 2 (1991) 196-201
13. Metcalfe T.W., Doran R.M., Rowlands P.L., Curry A., and Lacey C.J. Microsporidial keratoconjunctivitis in a patient with AIDS. Br J Ophthalmol 76 3 (1992) 177-178
14. Diesenhouse M.C., Wilson L.A., Corrent G.F., Visvesvara G.S., Grossniklaus H.E., and Bryan R.T. Treatment of microsporidial keratoconjunctivitis with topical fumagillin. Am J Ophthalmol 115 3 (1993) 293-298
15. Franssen F.F., Lumeij J.T., and van Knapen F. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob Agents Chemother 39 6 (1995) 1265-1268